Steven D. Rhodes is an Assistant Professor in the Department of Pediatrics, Division of Hematology/Oncology/Stem Cell Transplant at Indiana University School of Medicine. He earned his M.D. and Ph.D. from the Indiana University School of Medicine. His clinical and research focus is on neurofibromatosis (NF). His laboratory focuses on understanding the cellular and molecular mechanisms that govern the progression of plexiform and atypical neurofibroma precursor tumors to malignant peripheral nerve sheath tumor, the leading cause of death in persons with neurofibromatosis type 1 (NF1). Dr. Rhodes serves as the Site Principal Investigator at Indiana University within the NF Clinical Trial Consortium, a multi-institutional collaborative dedicated to conducting clinical trials to advance treatments for NF. As a pediatric oncologist and co-director of the NF Multidisciplinary Program at the Indiana University Simon Comprehensive Cancer Center, his clinical practice is devoted to caring for patients with NF1, NF2, and Schwannomatosis.
Steven D. Rhodes is an Assistant Professor in the Department of Pediatrics, Division of Hematology/Oncology/Stem Cell Transplant at Indiana University School of Medicine. He earned his M.D. and Ph.D. from the Indiana University School of Medicine. His clinical and research focus is on neurofibromatosis (NF). His laboratory focuses on understanding the cellular and molecular mechanisms that govern the progression of plexiform and atypical neurofibroma precursor tumors to malignant peripheral nerve sheath tumor, the leading cause of death in persons with neurofibromatosis type 1 (NF1). Dr. Rhodes serves as the Site Principal Investigator at Indiana University within the NF Clinical Trial Consortium, a multi-institutional collaborative dedicated to conducting clinical trials to advance treatments for NF. As a pediatric oncologist and co-director of the NF Multidisciplinary Program at the Indiana University Simon Comprehensive Cancer Center, his clinical practice is devoted to caring for patients with NF1, NF2, and Schwannomatosis.